冬虫夏草
巨噬细胞极化
败血症
能量代谢
重编程
急性肾损伤
生物
新陈代谢
巨噬细胞
微生物学
医学
细胞
生物化学
免疫学
植物
内科学
体外
内分泌学
作者
Lin Chen,Tong Yang,Jiangpeng Wu,Guangqing Cheng,Minghong Zhao,Yanyan Zhou,Yin Kwan Wong,Junzhe Zhang,Qiuyan Guo,Huan Tang,Jigang Wang
出处
期刊:Acta Materia Medica
[Compuscript, Ltd.]
日期:2024-01-01
卷期号:3 (3)
被引量:1
标识
DOI:10.15212/amm-2024-0018
摘要
Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional medicine for the prevention, treatment, and prognostication of various diseases, because of its pleiotropic pharmacological properties. However, the potential pharmacological action of CS in sepsis-associated acute kidney injury (S-AKI) remains poorly understood. Herein, we investigated the potential pharmacological action of CS against S-AKI and the underlying mechanisms. CS treatment effectively ameliorated renal dysfunction and injury in mice with lipopolysaccharide (LPS)-induced S-AKI, as indicated by the suppression of inflammatory cytokine expression and secretion. Multi-omic analyses suggested that the promotion of mitochondrial energy metabolism might be a potential mechanism through which CS protects mice against S-AKI induced by LPS. Subsequent validation assays confirmed that CS treatment substantially restored the activity of mitochondrial complexes, mitochondrial membrane potential, and ATP production. Moreover, CS concomitantly promoted transition of M1 macrophages to M2 macrophages with increased oxidative phosphorylation, thus indicating that macrophage polarization may also be a potential target for S-AKI treatment. Our findings demonstrated that CS significantly ameliorated renal injury and inflammation in S-AKI by regulating mitochondrial energy metabolism and macrophage polarization, thus providing new insights into the clinical use of CS for the prevention and treatment of S-AKI.
科研通智能强力驱动
Strongly Powered by AbleSci AI